S&P 500   4,981.80 (+0.13%)
DOW   38,612.24 (+0.13%)
QQQ   425.61 (-0.40%)
AAPL   182.32 (+0.42%)
MSFT   402.18 (-0.15%)
META   468.03 (-0.68%)
GOOGL   142.55 (+1.01%)
AMZN   168.59 (+0.90%)
TSLA   194.77 (+0.52%)
NVDA   674.72 (-2.85%)
NIO   5.97 (+0.17%)
AMD   164.29 (-0.84%)
BABA   75.58 (+3.34%)
T   17.01 (+0.59%)
F   12.15 (-0.82%)
MU   81.49 (+0.97%)
CGC   3.44 (-2.82%)
GE   149.08 (+0.31%)
DIS   107.68 (-1.61%)
AMC   4.57 (-1.93%)
PFE   27.67 (+0.29%)
PYPL   57.48 (-1.96%)
XOM   104.86 (+2.05%)
S&P 500   4,981.80 (+0.13%)
DOW   38,612.24 (+0.13%)
QQQ   425.61 (-0.40%)
AAPL   182.32 (+0.42%)
MSFT   402.18 (-0.15%)
META   468.03 (-0.68%)
GOOGL   142.55 (+1.01%)
AMZN   168.59 (+0.90%)
TSLA   194.77 (+0.52%)
NVDA   674.72 (-2.85%)
NIO   5.97 (+0.17%)
AMD   164.29 (-0.84%)
BABA   75.58 (+3.34%)
T   17.01 (+0.59%)
F   12.15 (-0.82%)
MU   81.49 (+0.97%)
CGC   3.44 (-2.82%)
GE   149.08 (+0.31%)
DIS   107.68 (-1.61%)
AMC   4.57 (-1.93%)
PFE   27.67 (+0.29%)
PYPL   57.48 (-1.96%)
XOM   104.86 (+2.05%)
S&P 500   4,981.80 (+0.13%)
DOW   38,612.24 (+0.13%)
QQQ   425.61 (-0.40%)
AAPL   182.32 (+0.42%)
MSFT   402.18 (-0.15%)
META   468.03 (-0.68%)
GOOGL   142.55 (+1.01%)
AMZN   168.59 (+0.90%)
TSLA   194.77 (+0.52%)
NVDA   674.72 (-2.85%)
NIO   5.97 (+0.17%)
AMD   164.29 (-0.84%)
BABA   75.58 (+3.34%)
T   17.01 (+0.59%)
F   12.15 (-0.82%)
MU   81.49 (+0.97%)
CGC   3.44 (-2.82%)
GE   149.08 (+0.31%)
DIS   107.68 (-1.61%)
AMC   4.57 (-1.93%)
PFE   27.67 (+0.29%)
PYPL   57.48 (-1.96%)
XOM   104.86 (+2.05%)
S&P 500   4,981.80 (+0.13%)
DOW   38,612.24 (+0.13%)
QQQ   425.61 (-0.40%)
AAPL   182.32 (+0.42%)
MSFT   402.18 (-0.15%)
META   468.03 (-0.68%)
GOOGL   142.55 (+1.01%)
AMZN   168.59 (+0.90%)
TSLA   194.77 (+0.52%)
NVDA   674.72 (-2.85%)
NIO   5.97 (+0.17%)
AMD   164.29 (-0.84%)
BABA   75.58 (+3.34%)
T   17.01 (+0.59%)
F   12.15 (-0.82%)
MU   81.49 (+0.97%)
CGC   3.44 (-2.82%)
GE   149.08 (+0.31%)
DIS   107.68 (-1.61%)
AMC   4.57 (-1.93%)
PFE   27.67 (+0.29%)
PYPL   57.48 (-1.96%)
XOM   104.86 (+2.05%)

Creative Medical Technology (CELZ) News Today

$4.22
-0.09 (-2.09%)
(As of 02/21/2024 ET)
SourceHeadline
investing.com logoCreative Medical Technology Holdings Inc (CELZ)
investing.com - February 15 at 12:52 AM
benzinga.com logoSteven L White's Net Worth
benzinga.com - February 9 at 7:42 AM
marketbeat.com logo
marketbeat.com - December 20 at 10:18 AM
finance.yahoo.com logoCreative Medical Technology Holdings (NASDAQ:CELZ) Granted FDA Clearance To Begin Phase 1/2 Clinical Trial Of AlloStem(TM) For Addressing Chronic Lower Back Pain
finance.yahoo.com - December 20 at 9:45 AM
marketbeat.com logo
marketbeat.com - December 20 at 9:40 AM
msn.com logoCreative Medical to initiate trial of lower back pain treatment
msn.com - October 11 at 2:17 PM
markets.businessinsider.com logoCreative Medical Gets IRB Approval For StemSpine Trial Using AlloStem Cell Therapy
markets.businessinsider.com - October 10 at 9:28 AM
finance.yahoo.com logoCreative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain
finance.yahoo.com - October 10 at 9:28 AM
finance.yahoo.com logoWhat Makes Creative Medical Technology Holdings, Inc. (CELZ) a New Buy Stock
finance.yahoo.com - September 22 at 3:36 PM
finance.yahoo.com logoCreative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain
finance.yahoo.com - September 19 at 8:35 AM
finance.yahoo.com logoWhat Is Allogeneic Cell Therapy, And What’s Driving This Market’s 25%+ Annual Global Growth?
finance.yahoo.com - August 24 at 5:29 PM
benzinga.com logoWhat Is Allogeneic Cell Therapy, And What's Driving This Market's 25%+ Annual Global Growth?
benzinga.com - August 23 at 10:48 AM
msn.com logoCreative Medical Technology regains Nasdaq listing compliance
msn.com - June 28 at 9:02 AM
finance.yahoo.com logoCreative Medical Technology Holdings Provides Corporate Update
finance.yahoo.com - June 12 at 4:21 PM
finance.yahoo.com logoCreative Medical Technology Announces $2 Million Share Repurchase Program
finance.yahoo.com - June 12 at 4:21 PM
msn.com logoCreative Medical Technology Holdings announces reverse stock split to regain compliance
msn.com - June 9 at 3:36 PM
finance.yahoo.com logoCreative Medical Technology Holdings Announces Successful Completion of the First Phase of its Program with Greenstone Biosciences, Inc. to Develop Next Generation iPSC Pipeline for ImmCelz® Immunotherapy Platform
finance.yahoo.com - May 31 at 9:44 AM
msn.com logoCreative Medical Releases Data From StemSpine Procedure For Chronic Lower Back Pain
msn.com - May 18 at 4:09 PM
finance.yahoo.com logoCreative Medical Technology Holdings Announces Positive Top-Line Study Results for Chronic Lower Back Pain Utilizing its StemSpine® Procedure Using AlloStem™ Allogenic Cell Line
finance.yahoo.com - May 18 at 4:09 PM
finance.yahoo.com logoCreative Medical Technology Holdings First Quarter 2023 Earnings: US$0.075 loss per share (vs US$0.18 loss in 1Q 2022)
finance.yahoo.com - May 14 at 10:03 AM
msn.com logoCreative Medical (CELZ) Up 86% on Upbeat Diabetes Study Data
msn.com - April 13 at 6:09 PM
msn.com logoCreative Medical Technology Soars after Positive Drug Data
msn.com - April 12 at 3:53 PM
benzinga.com logoThinking about buying stock in Newmark Group, Exscientia, Pardes Biosciences, Creative Medical Technology, or Somalogic?
benzinga.com - April 12 at 10:53 AM
msn.com logoWhy Is Creative Medical Technology Stock Skyrocketing Today?
msn.com - April 12 at 10:53 AM
marketbeat.com logo
marketbeat.com - April 12 at 10:49 AM
finance.yahoo.com logoCreative Medical Technology Holdings Announces Filing of 2022 Form 10-K and Provides Business Update
finance.yahoo.com - April 4 at 10:24 AM
msn.com logoCreative Medical stock rises on seeking FDA orphan drug status for Brittle diabetes therapy
msn.com - March 23 at 2:54 PM
finance.yahoo.com logoCreative Medical Technology Files Orphan Drug Designation Application with the U.S. FDA Using the ImmCelz® Platform for the Treatment of Brittle Type 1 Diabetes
finance.yahoo.com - March 23 at 9:53 AM
finance.yahoo.com logoCreative Medical Technology Holdings Announces Key Milestones Regarding ImmCelz® Platform Development
finance.yahoo.com - March 21 at 12:44 PM
finance.yahoo.com logoCreative Medical Technology Holdings Engages Highly Respected International CRO for Phase 1 / 2 Clinical Trial to Treat Type 1 Diabetes Using CELZ-201
finance.yahoo.com - March 7 at 10:37 AM
finance.yahoo.com logoThree Year Follow-Up Results Confirm Efficacy of StemSpine® Procedure for Treating Chronic Lower Back Pain, with No Serious Adverse Effects
finance.yahoo.com - February 14 at 12:45 PM
benzinga.com logoThinking about buying stock in Creative Medical, Meta, Advanced Micro Devices, Carvana, or SeqLL?
benzinga.com - February 8 at 1:17 PM
marketwatch.com logoCreative Medical Technology Shares Double After Approval to Continue Clinical Trial
marketwatch.com - February 8 at 1:17 PM
msn.com logoCELZ More Than Doubles on Greenlight for Diabetes Therapy Trial
msn.com - February 8 at 1:17 PM
marketbeat.com logo
marketbeat.com - February 8 at 11:46 AM
marketbeat.com logo
marketbeat.com - February 8 at 11:33 AM
finance.yahoo.com logoCreative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of Novel Cell Therapy for the Treatment of Type 1 Diabetes
finance.yahoo.com - February 8 at 8:10 AM
finance.yahoo.com logoCreative Medical Technology Holdings Announces FDA Clearance of Investigational New Drug (IND) Application for AlloStem™, a Novel Cell Therapy for the Treatment of Type 1 Diabetes
finance.yahoo.com - November 3 at 10:42 AM
finance.yahoo.com logoCreative Medical Technology Holdings Develops AlloStem™ Clinical Cell Line
finance.yahoo.com - October 20 at 10:39 AM
seekingalpha.com logoCELZ Creative Medical Technology Holdings, Inc.
seekingalpha.com - September 15 at 10:54 PM
finance.yahoo.com logoCreative Medical Technology Announces Positive Top-Line Results for OvaStem® Pilot Study
finance.yahoo.com - July 28 at 10:13 AM
seekingalpha.com logoCreative Medical, Greenstone team up to develop next-gen stem cell pipeline
seekingalpha.com - June 15 at 1:35 PM
finance.yahoo.com logoCreative Medical Technology Holdings Announces Agreement with Greenstone Biosciences, Inc. for Development of a Next Generation iPSC Pipeline for its ImmCelz® Immunotherapy Platform
finance.yahoo.com - June 15 at 8:34 AM
seekingalpha.com logoCANG,CELZ and BTTX among pre market gainers
seekingalpha.com - May 26 at 5:09 AM
seekingalpha.com logoCreative Medical Technology slides on $17M private offering
seekingalpha.com - April 29 at 11:42 AM
barrons.com logoCreative Medical Technology Announces Progress in Developing a Reproducible Clinical Grade of the Company's ImmCelz(R) Product
barrons.com - April 22 at 7:30 PM
finance.yahoo.com logoCreative Medical Technology Announces Progress in Developing a Reproducible Clinical Grade of the Company's ImmCelz® Product
finance.yahoo.com - April 20 at 12:39 PM
finance.yahoo.com logoCreative Medical Technology to Showcase CaverStem® at American Urological Association Annual Meeting - Largest and Most Prominent Gathering of Urologists in the World
finance.yahoo.com - April 12 at 9:05 AM
benzinga.com logoMid-Afternoon Market Update: Dow Falls 180 Points; Creative Medical Technology Shares Spike Higher
benzinga.com - March 31 at 6:55 PM
finance.yahoo.com logoCreative Medical Technology Signs Master Collaboration Agreement with the University of Miami to Accelerate Development of ImmCelz® Supercharged Autologous Immunotherapy Platform
finance.yahoo.com - March 31 at 1:55 PM
Get Creative Medical Technology News Delivered to You Automatically

Sign up to receive the latest news and ratings for CELZ and its competitors with MarketBeat's FREE daily newsletter.



CELZ Media Mentions By Week

CELZ Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CELZ
News Sentiment

0.00

0.52

Average
Medical
News Sentiment

CELZ News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CELZ Articles
This Week

1

0

CELZ Articles
Average Week

Get Creative Medical Technology News Delivered to You Automatically

Sign up to receive the latest news and ratings for CELZ and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:CELZ) was last updated on 2/21/2024 by MarketBeat.com Staff